WHO ICTRP trial
A randomized, double-blind, placebo-controlled, multicenter evaluation of the…
EUCTR2006-002477-45-DE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2006-002477-45-DE |
|---|---|
| Public title | A randomized, double-blind, placebo-controlled, multicenter evaluation of the efficacy and safety of terguride tablets, administered orally for 3 months, to patients with fibromyalgia. |
| Scientific title | A randomized, double-blind, placebo-controlled, multicenter evaluation of the efficacy and safety of terguride tablets, administered orally for 3 months, to patients with fibromyalgia. |
| Primary sponsor | ErgoNex Pharma GmbH |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Czech Republic;Germany |
| Conditions | fibromyalgia MedDRA version: 8.1 Level: LLT Classification code 10048439 Term: Fibromyalgia |
| Interventions | Product Name: Terguride 0.5 mg tablet Pharmaceutical Form: Tablet INN or Proposed INN: Terguride CAS Number: 37686-84-3 Other descriptive name: Transdihydrolisuride Concentration unit: mg milligram(s) Concentration type: equal Concentration… |
| Registration date | Nov 13, 2006 |
| Target size | 72 |
| Secondary IDs | ERX_01_05 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: